See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Liberation Day
Trade War
Natural Disasters
Social Media
Donald Trump
Stock Markets
Recession
Artificial Intelligence
Trade
Taxes
US Economy
Published • loading... • Updated

New Data to Be Presented at Upcoming Congresses Showcase Cerevance's Advanced Clinical ...

Summary by Hastings Tribune
Topline results from Phase 2 ASCEND trial of solengepras as a monotherapy treatment for early-stage Parkinson’s to be presentedFirst presentation of data from Phase 1 trial of novel KCNK13 inhibitor for CNS diseases targeting neuroinflammationAdditional meeting presentations highlight potential of…

1 Articles

All
Left
Center
1
Right
Hastings TribuneHastings Tribune
Center

New Data to Be Presented at Upcoming Congresses Showcase Cerevance's Advanced Clinical ...

Topline results from Phase 2 ASCEND trial of solengepras as a monotherapy treatment for early-stage Parkinson’s to be presentedFirst presentation of data from Phase 1 trial of novel KCNK13 inhibitor for CNS diseases targeting neuroinflammationAdditional meeting presentations highlight potential of…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Hastings Tribune broke the news in on Thursday, March 27, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Parkinson's Disease

Parkinson's Disease

Hastings, Nebraska

Hastings, Nebraska

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal